Mesoblast | MSB - Eigenkapital Und Reserven

Aktienkurs
2.02
Täglich Wechseln
0.04 1.76%
Monatlich
-4.27%
Jährlich
25.86%
Q2 Prognose
2.08




Eigenkapital Und Reserven Veränderung Datum
Avita Medical AUD -16.65M 3.76M 2025-12
Clinuvel Pharmaceuticals AUD 249.02M 8.21M 2025-12
Cochlear AUD 1.94B 12.2M 2025-12
CSL USD 18.66B 2.75B 2025-12
Pacific Edge NZD 26.9M 811K 2025-12
Paradigm Biopharmaceuticals AUD 6M 15.18M 2025-12
PYC Therapeutics AUD 147.18M 22.82M 2025-12
Ramsay Health Care AUD 4.79B 916.1M 2025-12
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Starpharma Holdings AUD 21.48M 2.48M 2025-12
Telix Pharmaceuticals AUD 416.86M 5.08M 2025-12